Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA

Core Viewpoint - Biotalys has received regulatory approval from the U.S. EPA for its first protein-based biofungicide, EVOCA, marking a significant milestone in agricultural technology [1][5]. Group 1: Product Overview - EVOCA is a precision biocontrol solution targeting fungal pathogens such as botrytis and powdery mildew in high-value fruits and vegetables, while minimizing risks to beneficial organisms and the environment [2]. - The product is designed to provide a novel solution that combines the efficacy of traditional chemistries with the environmental benefits of biological solutions [5][11]. - EVOCA has demonstrated strong performance in trials across various regions, climates, and crops, making it a versatile option for growers [10]. Group 2: Regulatory Progress - With EPA approval, Biotalys can now proceed with state registrations in California and Florida, critical regions for fruit and vegetable production in the U.S. [3][9]. - The company is also advancing the regulatory submission for EVOCA NG, a next-generation product expected to have a shorter review process due to its similar active ingredient and improved formulation [4]. Group 3: Market Potential - Biotalys anticipates that EVOCA NG will be registered in the U.S. by 2028-29 and in the EU and Brazil by 2029-30, with a combined market potential of approximately USD 1.2 billion [4]. - The approval of EVOCA and the upcoming registration of EVOCA NG highlight the potential of Biotalys' technology to shape the future of agriculture [5]. Group 4: Safety and Compliance - The EPA has exempted EVOCA's active ingredient residues on treated crops from tolerance requirements, indicating a strong safety profile for the product [6]. - EVOCA has received a FRAC code, recognizing its unique mode of action and contributing to its credibility in the market [7]. Group 5: Company Background - Biotalys is an AgTech company focused on developing precision biocontrol solutions based on proteins, aiming to address key crop pests and diseases throughout the agricultural value chain [11]. - Founded in 2013 as a spin-off from the VIB, Biotalys is based in Ghent, Belgium, and is listed on Euronext Brussels [11].